| 1 |
29026296 | Trends in health care resource utilization and pharmacological management of COPD in Taiwan from 2004 to 2010. | 2017 |
1 |
| 2 |
27003559 | Health Care Utilization and Costs After Initiating Budesonide/Formoterol Combination or Fluticasone/Salmeterol Combination Among COPD Patients New to ICS/LABA Treatment. | 2016 Mar |
1 |
| 3 |
25586493 | Comparative efficacy of long-acting muscarinic antagonists in preventing COPD exacerbations: a network meta-analysis and meta-regression. | 2015 Feb |
1 |
| 4 |
23378756 | The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease. | 2013 |
1 |
| 5 |
21942463 | Comparative effectiveness of budesonide/formoterol and fluticasone/salmeterol for COPD management. | 2011 |
1 |
| 6 |
19717476 | Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study. | 2010 Mar |
1 |
| 7 |
20339822 | The role of combination inhaled corticosteroid/long-acting beta-agonist therapy in COPD management. | 2010 Jun |
1 |
| 8 |
15607121 | Mucociliary dysfunction in COPD: effect of current pharmacotherapeutic options. | 2005 |
1 |